Literature DB >> 2209016

Equine motor neuron disease; a preliminary report.

J F Cummings1, A de Lahunta, C George, L Fuhrer, B A Valentine, B J Cooper, B A Summers, C R Huxtable, H O Mohammed.   

Abstract

A spontaneous motor neuron disease or neuronopathy was identified in 10 horses from the northeastern United States. Signs of generalized weakness, muscle fasciculations, muscle atrophy and weight loss progressed over 1 to several months in young and old horses of various breeds. Pathologic studies revealed that degeneration and loss of motor neurons in the spinal cord and brain stem resulted in axonal degeneration in the ventral roots and peripheral and cranial nerves and denervation atrophy of skeletal muscle. Many spinal neurons were swollen, chromatolytic and contained neurofilamentous accumulations. Other cell bodies were shrunken and undergoing neuronophagia and some were lost and replaced by glia. This fatal equine motor neuron disease has not been reported previously and its cause has not been determined. The progressive weakness and wasting and the neuronal degenerative changes in these horses were similar to those described in people with sporadic amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

Entities:  

Mesh:

Year:  1990        PMID: 2209016

Source DB:  PubMed          Journal:  Cornell Vet        ISSN: 0010-8901


  14 in total

1.  Shivering in a thoroughbred mare.

Authors:  P C Davies
Journal:  Can Vet J       Date:  2000-02       Impact factor: 1.008

2.  Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease.

Authors:  Carrie J Finno; Heather J Kaese; Andrew D Miller; Giuliana Gianino; Thomas Divers; Stephanie J Valberg
Journal:  Vet Ophthalmol       Date:  2016-08-05       Impact factor: 1.644

Review 3.  Treatment of amyotrophic lateral sclerosis--what is the next step?

Authors:  A C Ludolph
Journal:  J Neurol       Date:  2000-12       Impact factor: 4.849

4.  Motor neuron disease in a quarter horse from Nova Scotia.

Authors:  J Lofstedt; B O Ikede
Journal:  Can Vet J       Date:  1994-08       Impact factor: 1.008

5.  Endothelial lipopigment as an indicator of alpha-tocopherol deficiency in two equine neurodegenerative diseases.

Authors:  J F Cummings; A de Lahunta; H O Mohammed; T J Divers; B A Summers; B A Valentine; C A Jackson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Differential expression of TAR DNA-binding protein (TDP-43) in the central nervous system of horses afflicted with equine motor neuron disease (EMND): a preliminary study of a potential pathologic marker.

Authors:  Iqbal El-Assaad; Jeremy A Di Bari; Koji Yasuda; Thomas J Divers; Brian A Summers; Alexander de Lahunta; Hussni Mohammed
Journal:  Vet Res Commun       Date:  2012-08-24       Impact factor: 2.459

7.  Eosinophilic cytoplasmic inclusions in sporadic equine motor neuron disease: an electron microscopic study.

Authors:  J F Cummings; A de Lahunta; B A Summers; H O Mohammed; T J Divers; B A Valentine; K Trembicki-Graves
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier.

Authors:  Hussni O Mohammed; Simon R Starkey; Korona Stipetic; Thomas J Divers; Brian A Summers; Alexander de Lahunta
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

9.  Equine motor neuron disease in 2 horses from Saskatchewan.

Authors:  Michelle L Husulak; Katharina L Lohmann; Kamal Gabadage; Chris Wojnarowicz; Fernando J Marqués
Journal:  Can Vet J       Date:  2016-07       Impact factor: 1.008

10.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.